Quanta Inc (fka QNTA)

[~MulaGreen~]

NEWS!!!Medolife Rx Announces Successful Stability Results On Escozine Conjugated With Radioactive Iodine

https://www.barchart.com/story/news/1984371/medolife-rx-announces-successful-stability-results-on-escozine-conjugated-with-radioactive-iodine

The Company performed this preclinical study in advance of its impending Pharmacokinetic (PK) study on Escozine(R), the next step outlined by the FDA in its response to the Company regarding its Pre-IND submission as a COVID-19 drug.
PK studies are designed to measure the body's intake and clearing of active pharmaceutical ingredients (APIs), which in Medolife's case is the polarized scorpion venom peptide in Escozine(R).
An important mechanism of action of the peptide is that it binds only to cancer cells, leaving healthy cells untouched.
The peptide in Escozine(R) can also pass the blood-brain barrier, which allows the compound to bind with some of the deadliest types of cancers, such as glioblastomas (brain tumors).
Conjugation of Escozine(R) with radioactive iodine allows for researchers to more clearly see where and how Escozine(R) is absorbed and processed in the body.
Many APIs do not remain stable when conjugated with radioactive iodine, eliminating the possibility of certain types of PK studies. However, through this preclinical study, Medolife has proven the stability of Escozine(R) paired with radioactive iodine and is prepared to move into a full PK study per the guidelines given by the FDA.